Divis Laboratories to spend Rs 15 billion on expansion by next year

The company said it would be investing Rs 6 billion each on its Unit-2 at the Vizag SEZ in Andhra and Unit-1 of its Nalgonda SEZ in Telangana

v
Premium

Pharma Stocks, Sun Pharma, Cadila, Cipla

B Dasarath Reddy Hyderabad
Divis Laboratories, maker of active pharmaceutical ingredients (APIs) and drug intermediates, will spend Rs 15 billion to expand existing facilities over the next 15 months.

The company said it would be investing Rs 6 billion each on its Unit-2 at the Vizag SEZ in Andhra and Unit-1 of its Nalgonda SEZ in Telangana. And, another Rs 3 billion for de-bottlenecking at Vizag. All the work is expected to be complete by end-December 2019. The company currently operates four multipurpose manufacturing facilities, from these two sites. 

The management said the investment was to cater for the rising opportunities in generic and

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Oct 30 2018 | 5:30 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com